BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10441598)

  • 1. The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
    Hubert A; Peretz T; Manor O; Kaduri L; Wienberg N; Lerer I; Sagi M; Abeliovich D
    Am J Hum Genet; 1999 Sep; 65(3):921-4. PubMed ID: 10441598
    [No Abstract]   [Full Text] [Related]  

  • 2. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
    Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
    Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
    Lehrer S; Fodor F; Stock RG; Stone NN; Eng C; Song HK; McGovern M
    Br J Cancer; 1998 Sep; 78(6):771-3. PubMed ID: 9743298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
    Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D
    Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
    Moslehi R; Chu W; Karlan B; Fishman D; Risch H; Fields A; Smotkin D; Ben-David Y; Rosenblatt J; Russo D; Schwartz P; Tung N; Warner E; Rosen B; Friedman J; Brunet JS; Narod SA
    Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
    Hartge P; Struewing JP; Wacholder S; Brody LC; Tucker MA
    Am J Hum Genet; 1999 Apr; 64(4):963-70. PubMed ID: 10090881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Founder BRCA1/2 mutations among male patients with breast cancer in Israel.
    Struewing JP; Coriaty ZM; Ron E; Livoff A; Konichezky M; Cohen P; Resnick MB; Lifzchiz-Mercerl B; Lew S; Iscovich J
    Am J Hum Genet; 1999 Dec; 65(6):1800-2. PubMed ID: 10577940
    [No Abstract]   [Full Text] [Related]  

  • 8. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N; Kotar K; Foulkes WD
    BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.
    Chodick G; Struewing JP; Ron E; Rutter JL; Iscovich J
    Eur J Med Genet; 2008; 51(2):141-7. PubMed ID: 18158280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.
    Hodgson SV; Heap E; Cameron J; Ellis D; Mathew CG; Eeles RA; Solomon E; Lewis CM
    J Med Genet; 1999 May; 36(5):369-73. PubMed ID: 10353781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.
    Kreiss Y; Barak F; Baruch RG; Levy-Lahad E; Pras E; Friedman E
    Genet Test; 2000; 4(4):403-7. PubMed ID: 11216667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB; Boyd AA; Volcik K; Richards CS
    Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
    Tobias DH; Eng C; McCurdy LD; Kalir T; Mandelli J; Dottino PR; Cohen CJ
    Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.
    Gilbert F; Dabney MK; Diemer K; Ludwig S; Rosenthal G; Osborne MP
    Ann N Y Acad Sci; 1997 Dec; 833():198-203. PubMed ID: 9616755
    [No Abstract]   [Full Text] [Related]  

  • 15. Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.
    Nastiuk KL; Mansukhani M; Terry MB; Kularatne P; Rubin MA; Melamed J; Gammon MD; Ittmann M; Krolewski JJ
    Prostate; 1999 Aug; 40(3):172-7. PubMed ID: 10398279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the probability that Ashkenazi Jewish women carry a founder mutation in BRCA1 or BRCA2.
    Hopper JL; Jenkins MA
    Am J Hum Genet; 1999 Dec; 65(6):1771-6. PubMed ID: 10577931
    [No Abstract]   [Full Text] [Related]  

  • 17. The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.
    Bahar AY; Taylor PJ; Andrews L; Proos A; Burnett L; Tucker K; Friedlander M; Buckley MF
    Cancer; 2001 Jul; 92(2):440-5. PubMed ID: 11466700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
    Struewing JP; Hartge P; Wacholder S; Baker SM; Berlin M; McAdams M; Timmerman MM; Brody LC; Tucker MA
    N Engl J Med; 1997 May; 336(20):1401-8. PubMed ID: 9145676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.
    Friedman E; Bar-Sade Bruchim R; Kruglikova A; Risel S; Levy-Lahad E; Halle D; Bar-On E; Gershoni-Baruch R; Dagan E; Kepten I; Peretz T; Lerer I; Wienberg N; Shushan A; Abeliovich AD
    Am J Hum Genet; 1998 Oct; 63(4):1224-7. PubMed ID: 9758598
    [No Abstract]   [Full Text] [Related]  

  • 20. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.